CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −514 | 38,416 | ||
| 2024-07-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −8,230 | 30,186 | ||
| 2024-07-01 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −2,000 | $68.63 | $137K | 96,380 |
| 2024-06-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +3,639 | 138,622 | ||
| 2024-06-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −1,662 | $65.25 | $108K | 136,960 |
| 2024-06-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,639 | 42,768 | ||
| 2024-06-10 | Patterson Sandra SVP, Controllership | Option exercise | +901 | 33,533 | ||
| 2024-06-10 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −255 | $65.25 | $17K | 33,278 |
| 2024-06-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −901 | 17,762 | ||
| 2024-06-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +10,295 | 495,142 | ||
| 2024-06-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −4,693 | $65.25 | $306K | 490,449 |
| 2024-06-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −10,295 | 125,567 | ||
| 2024-06-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +3,751 | 122,183 | ||
| 2024-06-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −1,714 | $65.25 | $112K | 120,469 |
| 2024-06-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −3,751 | 43,697 | ||
| 2024-06-10 | Parsey Merdad Chief Medical Officer | Option exercise | +3,820 | 100,124 | ||
| 2024-06-10 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −1,744 | $65.25 | $114K | 98,380 |
| 2024-06-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −3,820 | 44,394 | ||
| 2024-06-10 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +638 | 14,752 | ||
| 2024-06-10 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −204 | $65.25 | $13K | 14,548 |
Page 26 of 30 · 599 trades